For example, m6A-forming enzyme METTL3 promotes the expression of BCL2, c-MYC and PTEN in human AML MOLM13 cells to control myeloid differentiation [12], and changes in the m6A regulatory gene lead to poor survival in AML patients [13]. This evidence concerns the gene BCL2 and acute myeloid leukemia.